An audit of outcome of treatment in acromegaly

QJM

Volumn 86, Issue 5, 1993, Pages 293-299

  Bates, A S ^a   Hoff, W V ^a   Jones, J M ^b   Clayton, R N ^a  

^a UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; DOPAMINE RECEPTOR STIMULATING AGENT; GROWTH HORMONE;

ACROMEGALY; ADULT; AGED; ARTICLE; CAUSE OF DEATH; DIABETES MELLITUS; FEMALE; GROWTH HORMONE RELEASE; HUMAN; HYPERTENSION; LIFE TABLE; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MORTALITY; PRIORITY JOURNAL; UNITED KINGDOM;

ACROMEGALY; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; DIABETES MELLITUS; ENGLAND; FEMALE; FOLLOW-UP STUDIES; GROWTH HORMONE; HUMAN; HYPERTENSION; MALE; MEDICAL AUDIT; MIDDLE AGE; PROGNOSIS; TREATMENT OUTCOME;

EID: 0027300715     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/oxfordjournals.qjmed.a068816     Document Type: Article

References (17)

1. Alexander L, Appleton D, Hall R, Ross WM, Wilkinson R. Epidemiology of acromegaly in the Newcastle region Clin Endocrmol 1980; 12:71-9
2. Wright AD, Hill DM, Lowy C, Fraser TR. Mortality in acromegaly. Q J Med 1969; 39:1-16.
3. Nabarro JDN. Acromegaly, Clin Endocrinol 1987; 26:481-512.
4. Bengtsson B, Eden S, Ernest I, Oden A, Sjogren B. Epidemiology and long term survival in Acromegaly Acta Med Scand 1988; 223:327-35.
5. Ron, Cridley C, Hrubec H, Page W, Arora S, Fraumeni JF. Acromegaly and gastrointestinal cancer. Cancer 1991; 68:1673-7
6. Armitage P, Berry C. Statistical Methods in Medical Research 2nd edn. Oxford, Blackwell Scientific Publications, 1987:438-9.
7. Tucker HSG, Crubb SR, Wigand JP, Watlington CO, Blackard WC, Becker DP. The treatment of acromegaly by transphenoidal surgery. Arch Intern Med 1980; 140:795-802
8. Baha'uddin M, Brodkey JS, Kaufman B, Velasco M, Manni A, Pearson OH Transphenoidal microsurgery in the treatment of acromegaly and gigantism. J Clin Endocrmol Metab 1980; 50:578-85.
9. Ho KY, Weissberger AJ, Marbach P, Lazarus L Therapeutic efficacy of Somatostatin analogue SMS 201- 995 (octreotide) in acromegaly. Ann Intern Med 1990, 112.173-81
10. Lamberts SWJ, Uitteriinden P, Schuijff PC Ktijn JGM. Therapy of acromegaly with Sandostatin: the predictive value of an acute test, the value of serum somatomedinc measurements in dose adjustment and the definition of a biochemical 'cure'. Clin Endocnnol 1988; 29:411-20.
11. Lindholm J, Giwercman B, Giwercman A, Astrup, J, Bjerre P, Skakkebaek NE. Investigation of the critena for assessing the outcome of treatment in acromegaly. Clin Endocrinol 1987; 27553-62.
12. Klibanski A, Zervas NT. Diagnosis and management of hormone secreting pituitary adenomas New Engl I Med 1991; 324:822-31
13. Ross DA, Wilson CB Results of transphenoidal microsurgery for growth hormone secreting pituitary adenoma in a senes of 214 patients. I Neurosurg 1988, 68:854-67
14. Serri O, Somma M, Comtois R, etal. Acromegaly: biochemical assessment of cure after long term follow up of transphenoidal selective adenomectomy J Clin Endocrmol Metab 1985; 61 1185-9
15. Rosen T, Bengtsson B. Premature mortality due to cardiovascular disease in hypopituitarism Lancet 1990; 336.285-8.
16. Wass JAH, Laws ER, Randall RV, Sheline CE. The treatment of acromegaly Clin Endocnnol Metab 1986, 15:683-707
17. Harris AC, Prestele H, Herald K, Boerhn V Long term efficacy of Sandostatin in 178 acromegalic patients: results from the international multicenter acromegaly study group In Lamberts SW, ed. Sandoslalm in the Treatment ol Acromegaly Berlin, Springer, 1988 117